Bone Marrow TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell TransplantationBone MarrowBone Marrow CellsGraft vs Host DiseaseTreatment OutcomeWhole-Body IrradiationBone and BonesTransplantation ConditioningAnemia, AplasticLeukemiaTransplantation ChimeraLiver TransplantationCombined Modality TherapyGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingCyclophosphamideHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityRecurrenceRetrospective StudiesTransplantation, IsogeneicBone Marrow DiseasesTime FactorsKidney TransplantationHematopoiesisImmunosuppressive AgentsHematologic NeoplasmsLeukemia, Myeloid, AcuteSurvival AnalysisRemission InductionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLRadiation ChimeraFatal OutcomeStem Cell TransplantationAcute DiseaseBone Marrow ExaminationHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisFollow-Up StudiesGraft RejectionAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinSurvival RateTransplantation ImmunologyLeukemia, MyeloidBone RemodelingBone Marrow NeoplasmsImmunosuppressionLymphocyte DepletionT-LymphocytesGraft vs Host ReactionDisease-Free SurvivalLeukocyte TransfusionHeart TransplantationSevere Combined ImmunodeficiencyHLA AntigensMyelodysplastic SyndromesColony-Forming Units AssayHodgkin DiseaseHematologic DiseasesChimeraCarmustineActuarial AnalysisLymphocyte TransfusionLung TransplantationCyclosporineMelphalanBone DensityGraft vs Tumor EffectCytarabineGraft vs Leukemia EffectProspective StudiesMultiple MyelomaCell DifferentiationCytomegalovirus InfectionsOrgan TransplantationNuclear FamilyMethotrexateEtoposideLeukocyte CountGranulocyte Colony-Stimulating FactorPancytopeniaFlow CytometryLymphomaRisk FactorsPostoperative ComplicationsSpleenVincristineCells, CulturedPeripheral Blood Stem Cell TransplantationMice, Inbred BALB CBlood Transfusion, Autologous